Author: therawinformant

  • 2 of the best international ETFs that ASX investors can buy today

    businessman holding world globe in one hand, international investment, asx shares

    If you don’t have the funds required to invest across a large number of different shares in order to maintain a diverse portfolio, then exchange traded funds (ETFs) could be the answer.

    This is because ETFs give investors the option to invest in anything from tens to thousands of companies through just a single investment. This includes investing in themes, indices, countries, and industries.

    While there are countless ETFs to choose from, two which I would buy are listed below. Here’s why I think they are among the best on offer:

    BetaShares Asia Technology Tigers ETF (ASX: ASIA)

    One of my favourites ETFs is the BetaShares Asia Technology Tigers ETF. Given how quickly the Asian economy is expected to grow over the next decade, having exposure to this side of the world seems like a particularly good idea to me. And what better group of shares to invest in than the 50 largest technology and ecommerce companies that have their main area of business in the region. These companies are among the fastest-growing in the region and look exceptionally well-positioned to be market-beaters over the next decade. Among its biggest holdings you’ll find the likes of ecommerce giant Alibaba, search engine Baidu, online retailer JD.com, and WeChat owner Tencent.

    BetaShares NASDAQ 100 ETF (ASX: NDQ)

    Another of my favourite ETFs is the BetaShares NASDAQ 100 ETF. This fund gives investors exposure to the 100 largest non-financial businesses on Wall Street’s technology-focused NASDAQ index. This means that through a single investment, investors will be getting exposure to some of the biggest and well-known companies in the world. This includes the likes of Amazon, Alphabet, Apple, Facebook, Microsoft, and Netflix, Tesla, and Zoom. Given the very positive long term outlooks of the majority of shares in the ETF, I believe it has the potential to provide investors with strong returns over the next decade.

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of BETANASDAQ ETF UNITS. The Motley Fool Australia owns shares of and has recommended BetaShares Asia Technology Tigers ETF. The Motley Fool Australia has recommended BETANASDAQ ETF UNITS. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 2 of the best international ETFs that ASX investors can buy today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3i9cuBM

  • 3 ASX shares with generous dividend yields to buy today

    stack of coins spelling yield, asx dividend shares

    With interest rates at their lowest levels in history and unlikely to move higher for some time, I believe dividend shares remain the best place to earn an income.

    But which ASX dividend shares should you buy? I think these would be top options right now:

    Aventus Group (ASX: AVN)

    Aventus is a retail property company which specialises in large format retail parks. It currently has a total of 20 centres which are home to a diverse tenant base of 593 quality tenancies. This includes major retailers such as ALDI, Bunnings, Officeworks, and The Good Guys. I like Aventus due to the way its portfolio is weighted heavily towards everyday needs. I believe this means it is better positioned than many property companies to ride out the pandemic. Goldman Sachs is very positive on the company and has forecast a sizeable ~17.3 cents per unit distribution in FY 2021. Based on the current Aventus share price, this equates to a very generous forward 8.2% distribution yield

    Coles Group Ltd (ASX: COL)

    Another option to consider buying is Coles. I think the supermarket giant is well-positioned to grow its earnings and dividend at a solid rate over the next decade. This is due to its defensive qualities, positive sales growth outlook, and potential margin expansion from its refreshed strategy. Based on the latest Coles share price, I estimate that it provides investors with a fully franked ~3.4% FY 2021 dividend yield.

    Lendlease Group (ASX: LLC)

    A final dividend share to consider buying is Lendlease. It hasn’t been a great 12 months for the international property and infrastructure company. However, I’m feeling confident that the worst is behind it. In light of this and its burgeoning global development pipeline, I believe now could be an opportune time to invest. Especially for income investors. I estimate that it will pay a 57 cents per share dividend next year. Based on the current Lendlease share price, this equates to a 5.1% dividend yield.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of COLESGROUP DEF SET. The Motley Fool Australia has recommended AVENTUS RE UNIT. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 3 ASX shares with generous dividend yields to buy today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/31mhOuK

  • These ASX shares are actively fighting coronavirus

    small figure representing ASX shares with cape and shield fighting coronavirus

    The coronavirus situation in Victoria seems to be worsening by the day. With a nightly curfew and even tighter lockdown laws taking effect at midnight tonight, the state appears to be under siege. Some ASX shares are actively playing a part in the fight against the virus and the treatment of patients. As the battle against the pandemic increasingly becomes a war, we take a look at two ASX shares involved in the fight against COVID-19. 

    2 ASX shares fighting against coronavirus

    Mesoblast Limited (ASX: MSB)

    Mesoblast is a regenerative medicine company seeking to provide treatments for inflammatory illnesses. The company has a portfolio of phase 3 product candidates including remestemcel-L, which is being trialed in the treatment of severe acute respiratory distress syndrome (ARDS) due to COVID-19 infection. 

    Interim analysis of the phase 3 trial of remestemcel-L in COVID-19 patients is set for early September. The trial’s first 90 patients will complete 30-day follow ups in August. After this, the Data Safety Monitoring Board will assess the interim data and determine whether the trial should proceed or stop early. There are currently no approved treatments for ARDS in COVID-19 patients, so if Mesoblast’s treatment is approved it would be a first. With ARDS the primary cause of death in COVID-19 patients, demand for an effective treatment is high. 

    Remestemcel-L was originally developed to treat acute graft versus host disease (GVHD). An application for the use of the treatment in children with the disease is being assessed by the United States FDA (Food and Drug Administration). If approved, Mesoblast plans to launch in the US this year with product inventory in place. 

    Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) 

    Fisher & Paykel Healthcare manufactures products used in respiratory and acute care. In the respiratory market since 1971, Fisher & Paykel Healthcare’s products are now being used in the treatment of coronavirus patients. The company’s respiratory humidifiers and consumables are directly involved in COVID-19 treatment. Fisher & Paykel has seen an increase in demand globally since the start of the pandemic and has ramped up production accordingly. 

    A weaker New Zealand dollar also contributed to Fisher & Paykel’s strong result for the year ended 31 March 2020. Operating revenue increased 18% over the previous year to $1.26 billion. This increase was driven by demand for products to treat COVID-19 patients and strong hospital hardware sales throughout the year. Revenue grew 25% in the hospital group, which includes respiratory and acute care products. Sales of consumables were up 23% over the previous year. This added up to a 37% increase in net profit after tax, with a final dividend of 15.5 cents per share declared. 

    Foolish takeaway 

    These two ASX shares provide products and treatments used to combat the coronavirus in those afflicted. Until a vaccine is found, these ASX shares should see steady demand. 

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Kate O’Brien has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post These ASX shares are actively fighting coronavirus appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3gFBobO

  • Novavax’s COVID-19 Vaccine Has an Edge Over Rivals, Says 5-Star Analyst

    Novavax’s COVID-19 Vaccine Has an Edge Over Rivals, Says 5-Star AnalystThe coronavirus isn’t going away just yet. The number of cases in the US passed 4.5 million, bringing the total number of US deaths to 158K.The need for a vaccine could not be more profound. While the data is alarming, the good news is that with each passing day, a vaccine solution is closer to becoming a reality. There are several candidates in the race hoping to be first to market. B.Riley FBR analyst Mayank Mamtani believes Novavax’s (NVAX) vaccine candidate, NVX-CoV2373, could make its way from the back of the pack to the front.Mamtani said, “While acknowledging the 6-8 week lag in terms of time to market entry relative to three leading vaccine candidates from AZ, MRNA, and PFE/BNTX, we highlight the potential of NVX-CoV2373 to demonstrate the most potent immune response, as assessed primarily by neutralizing titers and memory T cell immunity. This, coupled with differentiation on reactogenicity profile, particularly relative to mRNA-based approaches, supports our conviction for '2373 to become the preferred vaccine of choice in the elderly population.”Supporting Mamtani’s argument that Novavax’s offering could become popular with the elderly are the results from another study. In the Phase 3 trial of Novavax’s flu vaccine, NanoFlu, which is also based on its adjuvanted nanoparticle vaccine platform, reactogenicity compared favorably to the market leader, Fluzone. In comparison, both Moderna’s mRNA-1273 and Pfizer/BNTX’s BNT162b1 elicited flu-like symptoms in 75-100% of subjects. Although these were relatively mild and self-resolving, they nonetheless indicate NVAX’s candidate could have specific advantages.Accordingly, with this week’s possible publication of immunogenicity and safety data from NVX-CoV2373’s Phase 1 trial representing another potential catalyst, Mamtani boosts his price target for NVAX yet again. The figure is moved from $155 to $184, implying potential upside of 25%. The 5-star analyst’s Buy rating remains intact. (To watch Mamtani’s track record, click here)Overall, the rest of the Street is not quite as confident. Based on 3 Buys and 2 Holds, Novavax has a Moderate Buy consensus rating. Overall, the analysts believe the biotech has surged enough for now (up by 3,850% year-to-date) and expect Novavax shares to decline by 22% over the coming months, as indicated by the $123 average price target. (See Novavax stock analysis on TipRanks)To find good ideas for healthcare stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.

    from Yahoo Finance https://ift.tt/30tq7FX

  • 3 ASX dividend shares raising their dividends like clockwork

    asx dividend shares

    asx dividend sharesasx dividend shares

    ASX dividend shares could be the only way to make good income from your money at the moment.

    I’m not talking about some blue chip shares like Westpac Banking Corp (ASX: WBC) or Transurban Group (ASX: TCL). Income investors haven’t been able to rely on reliable dividend payments from them in 2020.

    I’m talking about ASX dividend shares with reliable business models that continue to increase their income payments to shareholders even through COVID-19.

    A business that can increase its dividend during this period is definitely worth considering for an income portfolio:

    Dividend share 1: APA Group (ASX: APA)

    APA is my preferred infrastructure ASX dividend share. It doesn’t require a certain number of air passengers or cars to generate its earnings.

    APA owns a large network of pipelines across Australia, it’s about 15,000 km in size. It actually delivers around half of Australia’s natural gas.

    The energy asset giant also owns (or has interests in) gas storage facilities, gas-fired power stations and renewable energy generation (wind and solar).

    APA has grown its distribution every year for a decade and a half. It funds that distribution from its annual cashflow, which is regularly growing. As more projects and investments are completed, that cashflow increases and this will fund higher distributions over time.

    Based on the FY20 distribution, at the current APA share price, it offers a distribution yield of 4.5%. Not a bad starting yield for an ASX dividend share.

    Dividend share 2: Rural Funds Group (ASX: RFF)

    Rural Funds is an agricultural real estate investment trust (REIT). It owns a variety of farm types including almonds, macadamias, cattle, cotton and vineyards.

    As a farmer there are commodity risks, just like there are with miners. However, as a landlord Rural Funds isn’t exposed to those sorts of risks. It’s the tenant that takes on the operational risks.

    The farms are spread across states and climactic conditions, so Rural Funds is well diversified. It recently announced an $81.1 million sugar cane farm acquisition which it plans to progressively turn into macadamia orchards and the rest will be able to be used for cropping.

    The ASX dividend share aims to increase its distribution by 4% per annum, which it has been successful at doing since it first listed and started paying a distribution several years ago.

    We all need to keep eating food, so Rural Funds’ rental income should keep flowing from its quality tenants like JBS and Olam. That rental income is steadily growing thanks to contracted rental indexation of either a fixed 2.5% increase or it’s linked to CPI inflation, plus market reviews.

    Rural Funds has provided guidance of a FY21 distribution of 11.28 cents per share, which equates to a 5.4% yield at the current Rural Funds share price.  

    Dividend share 3: WAM Microcap Limited (ASX: WMI)

    WAM Microcap could be one of the best ASX dividend shares on the ASX in my opinion. It’s a listed investment company (LIC) run by Wilson Asset Management which invests in small cap ASX shares. Generally, those targets have market caps under $300 million.

    ASX small caps have the potential to make the biggest returns for investors because they’re not followed by many investors, so they’re priced lower. Those small businesses also have a lot of growth potential. It’s much easier growing a company’s market cap from $200 million to $400 million than it is to go from $20 billion to $40 billion.

    WAM Microcap can turn the investment returns it generates into a big, growing dividend for its shareholders. The WAM Microcap board have an aim of growing the dividend, assuming it makes sense to do so and it has sufficient profit reserves and franking credits.

    Since inception in June 2017, the WAM Microcap portfolio has returned 15.9% per annum before fees, expenses and taxes. That’s a very strong performance and allows it to fund a solid dividend.

    The ASX dividend share recently announced a bigger ordinary dividend, a special dividend and a capital raising. I am very likely to participate in that capital raising, even if I just do a fairly small purchase.

    At the current WAM Microcap share price, using the FY20 annual ordinary dividend of 6 cents per share, it has an ordinary grossed-up dividend yield of 5.9%.

    Foolish takeaway

    I really like each of these ASX dividend shares. Right now I think WAM Microcap could be the best pick. It has the highest yield and may it generate the strongest total returns over the long-term. But I think both APA and Rural Funds are likely to deliver very reliable cashflow over the next 12 months and beyond. 

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Tristan Harrison owns shares of RURALFUNDS STAPLED and WAM MICRO FPO. The Motley Fool Australia owns shares of and has recommended RURALFUNDS STAPLED. The Motley Fool Australia owns shares of APA Group and Transurban Group. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 3 ASX dividend shares raising their dividends like clockwork appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/31ih2zc

  • Disney reports mixed Q3 earnings

    Disney reports mixed Q3 earningsDisney unexpectedly posted an adjusted profit per share where a loss had been expected, after the coronavirus pandemic hit the company in its most lucrative theme parks, media networks and studio film businesses. Myles Udland, Seana Smith, Dan Roberts, and Jared Blikre discuss on Final Round.

    from Yahoo Finance https://ift.tt/31eCCo6

  • Virgin Galactic tumbles after earnings results

    Virgin Galactic tumbles after earnings resultsYahoo Finance’s Emily McCormick joins Kristin Myers to discuss the outlook for Virgin Galactic after the company reported a wider-than-expected second-quarter loss.

    from Yahoo Finance https://ift.tt/3a0cbX9

  • Union Pacific Says Its California Police Force Won’t Check Immigration Status

    Union Pacific Says Its California Police Force Won't Check Immigration StatusUnion Pacific's (NYSE: UNP) police force will not ask for the immigration status of people it comes across on Union Pacific's network in California, nor will the railroad work with any joint law enforcement task force whose sole purpose is to identify, detain or deport people who entered the U.S. illegally.These actions are according to Union Pacific's (UP) police force order, dated March 2020.UP's March order was in the news last week because the Southern California chapter of the American Civil Liberties Union (ACLU) said U.S. Immigration and Customs Enforcement (ICE) recently agreed to settle allegations that it refused to turn over documents that alluded to a relationship between ICE and UP. Civil liberties groups had filed a Freedom of Information Act request in September 2018 to receive ICE documents about its relationship with UP, according to the ACLU. The groups subsequently sued ICE and the U.S. Department of Homeland Security in March 2019. The groups argued that on six occasions, UP's police force detained individuals and then transferred custody of the individuals to ICE. The groups contended that the individuals were targeted because of their race or ethnicity and that their detention violated the Fourth Amendment, according to court filings.ICE settled with the groups before the U.S. District Court for the Central District of California, Western Division, on July 26 for $15,000. That settlement dismisses the case against ICE. The groups involved in the lawsuit were the Immigrant Defenders Law Center, Western State College of Law Immigration Clinic, Public Counsel and Esperanza Immigrant Rights Project at Catholic Charities.Meanwhile, as the lawsuit was occurring, the Southern California chapter of the ACLU said that it and other groups had pressed UP in a March 2019 "demand letter"  to address allegations that UP's railroad police had unconstitutionally stopped, arrested and detained individuals based on their race or ethnicity, and then transferred them to ICE."UP's collaboration with ICE threatened immigrant families and was inconsistent with the California Values Act," said Jessica Bansal, senior staff attorney with the ACLU Foundation of Southern California. "We are pleased the new policy cuts ties with ICE and will be monitoring closely to ensure the troubling practices revealed by the FOIA litigation do not return."ICE told FreightWaves that it doesn't comment on the specifics of litigation proceedings or outcomes.Speaking on background on the agency's immigration policies, an ICE official said it does not request for or expect non-immigration officials to enforce immigration statutes.Union Pacific's ResponseOf last week's developments, UP said it "remains committed to full observance with all federal, state, and local laws and regulations.  Consistent with this commitment, Union Pacific has policies in place to ensure its interactions with ICE are consistent with both Federal and California law."UP's March order says as a general policy, "personnel who encounter a non-employee on Union Pacific property shall not (a) use suspected immigration status as a factor in determining whether to confront, detain, or arrest the person; (b) ask the person to disclose his or her immigration status; (c) order the person to produce immigration documents; or (d) initiate contact with a federal immigration agency to report the person. UPPD personnel may contact any law enforcement agency at any time to request additional assistance if necessary for officer safety."Click here for more FreightWaves articles by Joanna Marsh.Related articles:CBP finds 48 alleged stowaways in BNSF, UP trains at borderTSA to require freight railroads to provide training addressing terrorist threatsGAO critical of "outdated" inspection practices at U.S. ports by Customs and Border Protection agentsPhoto by Levi Saunders on UnsplashSee more from Benzinga * Weekly Fuel Report: August 3, 2020 * "Land Is Plentiful" For APM Terminals Mobile Seaport Growth * Ports Remain Closed After Hurricane Isaias Makes Landfall(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    from Yahoo Finance https://ift.tt/39YcG3S

  • Prudential Posts Second Straight Loss on Strain of Low Rates

    Prudential Posts Second Straight Loss on Strain of Low Rates(Bloomberg) — Prudential Financial Inc. posted a second-straight quarterly loss and said it expects low interest rates will continue to weigh on results.The life insurer posted a net loss of $2.41 billion, compared with net income of $708 million a year earlier. The loss was driven in part by a decline in the value of its derivatives holdings due to tightening credit spreads. Asset-management unit PGIM was a bright spot.Key InsightsPrudential is looking to weather a low-interest-rate environment by repricing and pivoting to less rate-sensitive products, it said in an earnings statement Tuesday. The company cut its long-term forecast for U.S. interest rates by 50 basis points to 3.25%“We displayed resiliency amidst the effects of the pandemic and economic and market shocks while continuing to execute against our 2020 priorities with urgency,” Chief Executive Officer Charles Lowrey said in a statement. The company is on track to reach its cost-saving target of $140 million this year and is shifting its international business to higher-growth markets, he said.PGIM broke records for adjusted operating income of $324 million, and assets under management, which swelled 9% to $1.39 trillion. The division benefited from investment earnings, lower expenses, higher fees and fixed-income inflows.Prudential joins American International Group Inc. in feeling pain from the pandemic. AIG said on an earnings call earlier Tuesday that it had to pay out more death benefits due to the impact of the virus.Market ReactionShares closed 1.8% lower at $63.28. They’re down 32% this year.Get MoreEarnings per share beat forecasts. After-tax adjusted operating income was $1.85 a share, surpassing the $1.71 median estimate of 12 analysts.Prudential’s statement is here. Its presentation is here.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

    from Yahoo Finance https://ift.tt/39UgByZ